Inhibitory effect of thromboxane A2 synthetase inhibitor, DP-1904, on antigen-induced contraction of human lung parenchyma

Annals of Allergy, Asthma and Immunology

Volumn 77, Issue 6, 1996, Pages 483-487

  Fukushima, Chizu ^a   Shimoda, Terufumi ^a   Matsuse, Hiroto ^a   Takao, Atsuko ^a   Sakai, Hiroyuki ^a   Asai, Sadahiro ^b   Kohno, Shigeru ^a   Hara, Kohei ^a  

^a NAGASAKI UNIVERSITY   (Japan)

^b Sasebo Shiritsu Sogo Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

NAFAGREL; THROMBOXANE SYNTHASE INHIBITOR;

ARTICLE; BRONCHOSPASM; CONTROLLED STUDY; DRUG EFFECT; DRUG SCREENING; HUMAN; HUMAN TISSUE; LUNG PARENCHYMA; PRIORITY JOURNAL; RADIOALLERGOSORBENT TEST;

EID: 0030470397     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)63355-8     Document Type: Article

References (26)

1. Higgs GA, Moncada S, Salmon JA, et al. The source of thromboxane and prostaglandins in experimental inflammation. Br J Pharmacol 1983;79: 863-8.
2. Schleimer RP, MacGlashan DW Jr, Peters SP, et al. Characterization of inflammatory mediator release from purified human lung mast cells. Am Rev Respir Dis 1986;133:614-7.
3. 2 and prostacyclin from human lung parenchyma. Am Rev Respir Dis 1981;124: 402-6.
4. Jones GL, Saroea HG, Watson RM, et al. Effect of an inhaled thromboxane mimetic (U46619) on airway function in human subjects. Am Rev Respir Dis 1992;145:1270-4.
5. 2 production in allergen-induced immediate and late asthmatic responses. J Asthma 1988;25:117-24.
6. Lupinetti MD, Sheller JR, Catella F, et al. Thromboxane biosynthesis in allergen-induced bronchospasm. Am Rev Respir Dis 1989;140:932-5.
7. Kleeberger SR, Kolbe J, Adkinson NF, Jr, et al. The role of mediators in the response of the canine peripheral lung to 1 ppm ozone. Am Rev Respir Dis 1988;137:321-5.
8. 2 biosynthesis in acute asthma and after antigen challenge. Am Rev Respir Dis 1991; 143:119-25.
9. Creese BR, Temple DM. The mediators of allergic contraction of human airway smooth muscle: a comparison of bronchial and lung parenchymal strip preparations. Clin Exp Pharmacol Physiol 1986;13:103-11.
10. Ghelani AM, Holroyde MC, Sheard P. Response of human isolated and lung parenchymal strips to SRS-A and other mediators of asthmatic bronchospasm. Br J Pharmacol 1980;71:107-12.
11. Adkinson NF Jr. Prostaglandin production by human peripheral blood cells in vitro. J Lab Clin Med 1977;90: 1043-53.
12. Haye-Legrand I, Cerrina J, Raffestin B, et al. Histamine contraction of isolated human airway muscle preparations: role of prostaglandins. J Pharmacol Exp Ther 1986;239: 536-41.
13. Nanbu F, Motoishi M, Omawari N, et al. Inhibitory effects of OKY-046 on spasmogen-induced bronchoconstrictions in sensitized and non-sensitized guinea pigs. Jpn J Pharmacol 1990;52: 307-17.
14. Takami M, Takata Y, Matsumoto K, et al. Effect of DP-1904, a new thromboxane A2 synthetase inhibitor, on guinea pig experimental asthma. Ann N Y Acad Sci 1991;629:407-9.
15. 4 in humans. Am Rev Respir Dis 1990; 141:1441-5.
16. Taniguchi Y, Tamura G, Honma M, et al. The effect of an oral leukotriene antagonist, ONO-1078, on allergen-induced immediate bronchoconstriction in asthmatic subjects. J Allergy Clin Immunol 1993;92:507-12.
17. 4 receptor antagonist ICI 204, 219 given by the inhaled route inhibits the early but not the late phase of allergen-induced bronchoconstriction. Am Rev Respir Dis 1993;147:1431-5.
18. 4 antagonist, MK-679. Am Rev Respir Dis 1993;147:1442-6.
19. 4 receptor antagonist ICI 204, 219 against exercise-induced asthma. Am Rev Respir Dis 1993;147: 1413-8.
20. Friedman BS, Bel EH, Buntinx A, et al. Oral leukotriene inhibitor(MK-866) blocks allergen-induced airway responses. Am Rev Respir Dis 1993; 147:839-44.
21. 4 and antigen in vitro. Am Rev Respir Dis 1992;146: 923-9.
22. Kohno S, Tsuzuike N, Yamamura H, et al. Important role of peptide leukotrienes (p-LTs) in the resting tonus of isolated human bronchi. Jpn J Pharmacol 1993;62:351-5.
23. 2 antagonist, S-1452, in guinea pigs. Int Arch Allergy Immunol 1992;98:239-46.
24. Fujimura M, Sasaki F, Nakatsumi Y, et al. Effects of a thromboxane synthetase inhibitor (OKY-046) and a lipoxygenase inhibitor (AA861) on bronchial responsiveness to acetylcholine in asthmatic subjects. Thorax 1986;41:955-9.
25. Chung KF, Aizawa H, Becker AB, et al. Inhibition of antigen-induced airway hyperresponsiveness by a thromboxane synthetase inhibitor (OKY-046) in allergic dogs. Am Rev Respir Dis 1986;134:258-61.
26. Aizawa H, Chung KF, Leikauf GD, et al. Significance of thromboxane generation in ozone-induced airway hyperresponsiveness in dogs. Am Physiol Soc 1985;1918-23.